| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
AR
|
androgen receptor
|
|
ATIC
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
C5
|
complement component 5
|
|
C6ORF10
|
chromosome 6 open reading frame 10
|
|
C6ORF15
|
chromosome 6 open reading frame 15
|
|
CARD8
|
caspase recruitment domain family, member 8
|
|
CCBE1
|
collagen and calcium binding EGF domains 1
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CLEC16A
|
C-type lectin domain family 16, member A
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
DEK
|
DEK proto-oncogene
|
|
DLG5
|
discs, large homolog 5 (Drosophila)
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EXOC4
|
exocyst complex component 4
|
|
EXOC5
|
exocyst complex component 5
|
|
FAM167A
|
family with sequence similarity 167, member A
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GGH
|
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HFE
|
hemochromatosis
|
|
HLA-DMA
|
major histocompatibility complex, class II, DM alpha
|
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta
|
|
HLA-DOA
|
major histocompatibility complex, class II, DO alpha
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB2
|
major histocompatibility complex, class II, DR beta 2 (pseudogene)
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
IFNG
|
interferon, gamma
|
|
IL10
|
interleukin 10
|
|
IL12B
|
interleukin 12B
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL26
|
interleukin 26
|
|
IL3
|
interleukin 3
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
LECT1
|
leukocyte cell derived chemotaxin 1
|
|
LTA
|
lymphotoxin alpha
|
|
LTB
|
lymphotoxin beta (TNF superfamily, member 3)
|
|
LY6G6C
|
lymphocyte antigen 6 complex, locus G6C
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MEFV
|
Mediterranean fever
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSH5
|
mutS homolog 5
|
|
MTHFD1
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIL1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH4
|
notch 4
|
|
NRM
|
nurim (nuclear envelope membrane protein)
|
|
OLIG3
|
oligodendrocyte transcription factor 3
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PDCD1
|
programmed cell death 1
|
|
PGR
|
progesterone receptor
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PPT2
|
palmitoyl-protein thioesterase 2
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRRC2A
|
proline-rich coiled-coil 2A
|
|
PRRT1
|
proline-rich transmembrane protein 1
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RFC1
|
replication factor C (activator 1) 1, 145kDa
|
|
SAA1
|
serum amyloid A1
|
|
SALL3
|
spalt-like transcription factor 3
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SH2D2A
|
SH2 domain containing 2A
|
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble)
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
SUMO4
|
small ubiquitin-like modifier 4
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TFR2
|
transferrin receptor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TIMELESS
|
timeless circadian clock
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRAF5
|
TNF receptor-associated factor 5
|
|
TRB
|
T cell receptor beta locus
|
|
TYMS
|
thymidylate synthetase
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
